Insider Cluster (2 insiders) ·Filed Jul 13, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $503K total
Actionable Insight • Neutral

The cluster is too small to warrant a trading signal. CEO Rothblatt's sales are consistent with routine option exercise-and-sell patterns, and the Director's sale is a modest liquidity event. Monitor for any material change in insider selling volume or C-suite departures, but no immediate action is warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
UTHR ▼ -1.41% at T+20d
NEUTRAL call ✗ call lost -1.41% · α vs SPY -4.60% · entry $535.57 → $527.99
Next anchor: T+60d in 3d
Latest observation: T+56 +7.34% FF3 residual α
Entry anchored
Jul 10, 03:59 PM ET
via exchange tick
T+1d
-1.66%
call -1.66% · α -2.02%
$526.66
settled 3mo ago
T+5d
+0.02%
call +0.02% · α +0.80%
$535.67
settled 3mo ago
T+20d
-1.41%
call -1.41% · α -4.60%
$527.99
settled 8w ago
T+60d
—
call — · α —
—
in 3d

Price Chart

Loading chart...

Executive Summary

CEO Martine Rothblatt and Director Jan Malcolm sold a combined $503K in open-market UTHR shares on July 10, 2026. The CEO's sales are part of a larger pattern of option exercises and same-day sales, while the Director's sale is a modest liquidity event. At 0.002% of UTHR's $22.7B market cap, the cluster is trivial in size and carries no material signal.

Key Financial Metrics

Direction
selling
Total Value
$503.0K
Insiders
2

Key Facts

  • CEO Martine Rothblatt sold 600 shares at $540.37 for $324K on July 10, 2026
  • Director Jan Malcolm sold 325 shares at $550.59 for $179K on July 10, 2026
  • Total open-market sales: $503K, representing ~0.002% of UTHR's $22.7B market cap
  • CEO also exercised 9,500 options at $135.42 and sold additional shares on the same day, consistent with routine option exercise-and-sell patterns
  • Five directors exercised non-cash derivatives on July 9, 2026, with no associated open-market sales

Financial Impact

Total insider sales of $503K, negligible relative to $22.7B market cap

insider_ownership

Risk Factors

  • CEO continues to hold a large position — no signal of loss of confidence
  • No recent 10b5-1 plan disclosures to confirm pre-arranged nature of sales
  • Insider selling at UTHR has been persistent (8 sells totaling $4.0M in prior 30 days), but all are small relative to market cap

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1784008936872
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$573.51 (+14.62%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$573.51 (+15.37%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$573.51 (+13.82%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$573.51 (+13.16%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$573.51 (+17.62%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$573.51 (+17.48%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$573.51 (+11.26%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$573.51 (+8.64%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$573.51 (+11.00%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$573.51 (+11.00%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 14, 2026